SMaRT Therapeutics
SMaRT Therapeutics focuses on the discovery of small-molecule drugs that treat diseases by selectively targeting and modulating RNA.
- Stage Product In Development
- Industry Biotechnology
- Location Jupiter, FL, USA
- Currency USD
- Founded January 2011
- Website smart-therapeutics.com
Company Summary
SMaRT Therapeutics targets RNA for drugs. The company has received $9.6 million in grant funds from Scripps and NIH and is looking for additional investment to take its three most advanced drug candidates into clinical trials (myotonic dystrophy type I currently in bioanalytical testing, and myotonic dystrophy type II and fragile X syndrome, both in toxicology testing).
Team
Previous Investors
-
National Institutes of HEalthUnconfirmedSCripps ResearchUnconfirmedState University of NYUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.